Literature DB >> 26133610

Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera.

Brian W Miller1, Sofia H L Frost2, Shani L Frayo2, Aimee L Kenoyer2, Erlinda Santos2, Jon C Jones2, Damian J Green3, Donald K Hamlin4, D Scott Wilbur4, Darrell R Fisher5, Johnnie J Orozco2, Oliver W Press3, John M Pagel3, Brenda M Sandmaier3.   

Abstract

PURPOSE: Alpha-emitting radionuclides exhibit a potential advantage for cancer treatments because they release large amounts of ionizing energy over a few cell diameters (50-80 μm), causing localized, irreparable double-strand DNA breaks that lead to cell death. Radioimmunotherapy (RIT) approaches using monoclonal antibodies labeled with α emitters may thus inactivate targeted cells with minimal radiation damage to surrounding tissues. Tools are needed to visualize and quantify the radioactivity distribution and absorbed doses to targeted and nontargeted cells for accurate dosimetry of all treatment regimens utilizing α particles, including RIT and others (e.g., Ra-223), especially for organs and tumors with heterogeneous radionuclide distributions. The aim of this study was to evaluate and characterize a novel single-particle digital autoradiography imager, the ionizing-radiation quantum imaging detector (iQID) camera, for use in α-RIT experiments.
METHODS: The iQID camera is a scintillator-based radiation detection system that images and identifies charged-particle and gamma-ray/x-ray emissions spatially and temporally on an event-by-event basis. It employs CCD-CMOS cameras and high-performance computing hardware for real-time imaging and activity quantification of tissue sections, approaching cellular resolutions. In this work, the authors evaluated its characteristics for α-particle imaging, including measurements of intrinsic detector spatial resolutions and background count rates at various detector configurations and quantification of activity distributions. The technique was assessed for quantitative imaging of astatine-211 ((211)At) activity distributions in cryosections of murine and canine tissue samples.
RESULTS: The highest spatial resolution was measured at ∼20 μm full width at half maximum and the α-particle background was measured at a rate as low as (2.6 ± 0.5) × 10(-4) cpm/cm(2) (40 mm diameter detector area). Simultaneous imaging of multiple tissue sections was performed using a large-area iQID configuration (ø 11.5 cm). Estimation of the (211)At activity distribution was demonstrated at mBq/μg-levels.
CONCLUSIONS: Single-particle digital autoradiography of α emitters has advantages over traditional film-based autoradiographic techniques that use phosphor screens, in terms of spatial resolution, sensitivity, and activity quantification capability. The system features and characterization results presented in this study show that the iQID is a promising technology for microdosimetry, because it provides necessary information for interpreting alpha-RIT outcomes and for predicting the therapeutic efficacy of cell-targeted approaches using α emitters.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26133610      PMCID: PMC4464071          DOI: 10.1118/1.4921997

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  25 in total

Review 1.  Advancements in cancer therapy with alpha-emitters: a review.

Authors:  S K Imam
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-09-01       Impact factor: 7.038

2.  Potential and pitfalls of therapy with alpha-particles.

Authors:  Michael J Welch
Journal:  J Nucl Med       Date:  2005-08       Impact factor: 10.057

3.  Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.

Authors:  Michael R Zalutsky
Journal:  J Nucl Med       Date:  2006-08       Impact factor: 10.057

4.  A simple method for determining the modulation transfer function in digital radiography.

Authors:  H Fujita; D Y Tsai; T Itoh; K Doi; J Morishita; K Ueda; A Ohtsuka
Journal:  IEEE Trans Med Imaging       Date:  1992       Impact factor: 10.048

5.  Scintillating fiber optic screens: a comparison of MTF, light conversion efficiency, and emission angle with Gd2O2S:Tb screens.

Authors:  T Yu; J M Sabol; J A Seibert; J M Boone
Journal:  Med Phys       Date:  1997-02       Impact factor: 4.071

6.  Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.

Authors:  Damian J Green; Mazyar Shadman; Jon C Jones; Shani L Frayo; Aimee L Kenoyer; Mark D Hylarides; Donald K Hamlin; D Scott Wilbur; Ethan R Balkan; Yukang Lin; Brian W Miller; Sofia H L Frost; Ajay K Gopal; Johnnie J Orozco; Theodore A Gooley; Kelly L Laird; Brian G Till; Tom Bäck; Brenda M Sandmaier; John M Pagel; Oliver W Press
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

Review 7.  What happened to anti-CD33 therapy for acute myeloid leukemia?

Authors:  Joseph G Jurcic
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

8.  Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.

Authors:  G Sgouros; A M Ballangrud; J G Jurcic; M R McDevitt; J L Humm; Y E Erdi; B M Mehta; R D Finn; S M Larson; D A Scheinberg
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

9.  Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.

Authors:  Michael R Zalutsky; David A Reardon; Gamal Akabani; R Edward Coleman; Allan H Friedman; Henry S Friedman; Roger E McLendon; Terence Z Wong; Darell D Bigner
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

10.  Progress in BazookaSPECT: High-Resolution, Dynamic Scintigraphy with Large-Area Imagers.

Authors:  Brian W Miller; H Bradford Barber; Harrison H Barrett; Zhonglin Liu; Vivek V Nagarkar; Lars R Furenlid
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2012-08-12
View more
  6 in total

Review 1.  Radium-223 dichloride in clinical practice: a review.

Authors:  Luigia Florimonte; Luca Dellavedova; Lorenzo Stefano Maffioli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-28       Impact factor: 9.236

Review 2.  Internal microdosimetry of alpha-emitting radionuclides.

Authors:  Werner Hofmann; Wei Bo Li; Werner Friedland; Brian W Miller; Balázs Madas; Manuel Bardiès; Imre Balásházy
Journal:  Radiat Environ Biophys       Date:  2019-12-21       Impact factor: 1.925

Review 3.  Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET.

Authors:  Jin Su Kim
Journal:  Nucl Med Mol Imaging       Date:  2016-01-26

Review 4.  Radiopharmaceutical therapy in cancer: clinical advances and challenges.

Authors:  George Sgouros; Lisa Bodei; Michael R McDevitt; Jessie R Nedrow
Journal:  Nat Rev Drug Discov       Date:  2020-07-29       Impact factor: 84.694

5.  Involvement of eNAMPT/TLR4 signaling in murine radiation pneumonitis: protection by eNAMPT neutralization.

Authors:  Alexander N Garcia; Nancy G Casanova; Daniel G Valera; Xiaoguang Sun; Jin H Song; Carrie L Kempf; Liliana Moreno-Vinasco; Kimberlie Burns; Tadeo Bermudez; Mia Valdez; Genesis Cuellar; Taylor Gregory; Radu C Oita; Vivian Reyes Hernon; Christy Barber; Sara M Camp; Diego Martin; Zhonglin Liu; Christian Bime; Saad Sammani; Anne E Cress; Joe Gn Garcia
Journal:  Transl Res       Date:  2021-06-15       Impact factor: 7.012

6.  Actinide bioimaging in tissues: Comparison of emulsion and solid track autoradiography techniques with the iQID camera.

Authors:  Stephanie Lamart; Brian W Miller; Anne Van der Meeren; Anissa Tazrart; Jaime F Angulo; Nina M Griffiths
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.